Pulmonary Artery Denervation: Update on Clinical Studies

Area of Science:

• Cardiology
• Pulmonary Hypertension Research
• Interventional Cardiology

Background:

• Sympathetic overactivity is a key driver in the progression of pulmonary arterial hypertension (PAH).
• Targeting sympathetic nerves offers a potential therapeutic strategy for PAH management.

Purpose of the Study:

• To review the anatomical localization of pulmonary arterial sympathetic nerves.
• To outline the procedural steps of pulmonary artery denervation (PADN).
• To highlight the clinical outcomes associated with PADN in PAH patients.

Main Methods:

• Review of preclinical data and clinical trial outcomes.
• Description of the PADN procedure using an ablation catheter at the pulmonary artery bifurcation.
• Analysis of hemodynamic parameters and 6-minute walk distance (6MWD) in treated patients.

Main Results:

• Sympathetic nerves are predominantly found in the posterior region of the pulmonary trunk and bifurcation.
• PADN demonstrated a significant reduction in pulmonary arterial pressure.
• PADN improved hemodynamic parameters and increased 6MWD in patients with PAH and combined pre- and post-capillary pulmonary hypertension (CpcPH).

Conclusions:

• PADN is a promising interventional treatment for PAH and CpcPH, addressing sympathetic overactivity.
• The procedure has shown efficacy in improving clinical outcomes and hemodynamic status.
• Further clinical trials are necessary to validate the long-term efficacy of PADN.